文献速递系统性红斑狼疮

在学术性三级诊疗中心验证2019年EULAR/ACR系统性红斑狼疮分类标准

Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary care centre.
PubMed 文献 · RMD Open · 2023-01-01

在学术性三级诊疗中心的前瞻性和回顾性观察队列中纳入3377例患者,评估2019年EULAR/ACR系统性红斑狼疮分类标准的敏感度和特异度,并与1997年ACR及2012年SLICC标准比较。2019年标准敏感度高于1997年标准(87.0% vs 81.8%),但特异度较低(全队列98.1% vs 99.5%,非SLE自身免疫性风湿病患者96.5% vs 98.8%)。

要点

  • 2019年标准敏感度87.0%高于1997年标准81.8%,全队列特异度98.1%低于99.5%。
  • 在非SLE自身免疫性风湿病患者中,2019年标准特异度96.5%,低于1997年标准的98.8%。
  • 抗核抗体阳性史和抗dsDNA抗体是最敏感但最不特异的条目。

核心结论

  • 在该独立学术医学中心的队列中,2019年狼疮分类标准的敏感度和特异度得到确认。
  • 1997年与2019年标准的总体一致性非常好。

研究设计与样本

  • 前瞻性和回顾性观察性队列研究,纳入学术性三级诊疗中心门诊患者3377例:SLE 606例、非SLE自身免疫性风湿病1015例、非自身免疫性风湿病1756例(肝细胞癌、原发性胆汁性肝硬化、自身免疫性肝炎)。

主要发现

  • 2019年标准敏感度87.0%,高于1997年标准的81.8%。
  • 2019年标准全队列特异度98.1%,低于1997年标准的99.5%。
  • 在非SLE自身免疫性风湿病患者中,2019年标准特异度96.5%,低于1997年标准的98.8%。
  • SLE/非SLE自身免疫性风湿病患者的Youden指数分别为0.835和0.806。
  • 最敏感的条目为抗核抗体阳性史和抗dsDNA抗体检测,二者也是最不特异的条目;最特异的条目为III/IV型狼疮肾炎、低C3合并低C4补体水平,其次为II/V型狼疮肾炎、低C3或低C4补体水平、谵妄和精神病(当不能归因于非SLE原因时)。

关键数值与推荐

  • 2019年EULAR/ACR SLE分类标准敏感度87.0%、全队列特异度98.1%、非SLE自身免疫性风湿病患者特异度96.5%。
  • 1997年ACR标准敏感度81.8%、全队列特异度99.5%、非SLE自身免疫性风湿病患者特异度98.8%。
  • SLE/非SLE自身免疫性风湿病患者Youden指数:2019年标准0.835,1997年标准0.806。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the sensitivity and specificity of the 2019 EULAR/American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus (SLE) in outpatients at an academic tertiary care centre and to compare them to the 1997 ACR and the 2012 Systemic Lupus International Collaborating Clinics criteria. METHODS: Prospective and retrospective observational cohort study. RESULTS: 3377 patients were included: 606 with SLE, 1015 with non-SLE autoimmune-mediated rheumatic diseases (ARD) and 1756 with non-ARD diseases (hepatocellular carcinoma, primary biliary cirrhosis, autoimmune hepatitis). The 2019 criteria were more sensitive than the 1997 criteria (87.0% vs 81.8%), but less specific (98.1% vs 99.5% in the entire cohort and 96.5% vs 98.8% in patients with non-SLE ARD), resulting in Youden Indexes for patients with SLE/non-SLE ARD of 0.835 and 0.806, respectively. The most sensitive items were history of antinuclear antibody (ANA) positivity and detection of anti-double-stranded deoxyribonucleic acid (dsDNA) antibodies. These were also the least specific items. The most specific items were class III/IV lupus nephritis and the combination of low C3 and low C4 complement levels, followed by class II/V lupus nephritis, either low C3 or low C4 complement levels, delirium and psychosis, when these were not attributable to non-SLE causes. CONCLUSIONS: In this cohort from an independent academic medical centre, the sensitivity and specificity of the 2019 lupus classification criteria were confirmed. Overall agreement of the 1997 and the 2019 criteria was very good.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Schmidtmann I, Kraus D, Weinmann A, et al. Validation of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in an academic tertiary care centre. RMD Open. 2023. PMID: 37419524. doi:10.1136/rmdopen-2023-003037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。